BSE Live
Mar 04, 16:01Prev. Close
171.45
Open Price
165.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 04, 15:59Prev. Close
171.34
Open Price
167.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
171.21 (411)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 109.40 | 71.91 | 45.88 | -178.84 | -223.24 | |
| Net CashFlow From Operating Activities | 154.51 | 64.84 | 38.56 | -62.30 | -65.04 | |
| Net Cash Used In Investing Activities | -33.19 | -4.49 | -5.43 | -3.25 | 24.68 | |
| Net Cash Used From Financing Activities | 16.99 | -29.28 | -39.64 | 57.02 | 35.77 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 138.32 | 31.07 | -6.51 | -8.53 | -4.58 | |
| Cash And Cash Equivalents Begin of Year | 46.95 | 15.88 | 22.39 | 30.92 | 35.50 | |
| Cash And Cash Equivalents End Of Year | 185.27 | 46.95 | 15.88 | 22.39 | 30.92 |
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Buy Marksans Pharma; target of Rs 225: Choice Institutional Equities
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y